Update on Outcome Measure Development for Large Vessel Vasculitis: Report from OMERACT 12

OBJECTIVE: The rarity of large vessel vasculitis (LVV) is a major factor limiting randomized controlled trials in LVV, resulting in treatment choices in these diseases that are guided mainly by observational studies and expert opinion. Further complicating trials in LVV is the absence of validated a...

Full beskrivning

Sparad:
Bibliografiska uppgifter
I publikationen:J Rheumatol
Huvudupphovsmän: Aydin, Sibel Zehra, Direskeneli, Haner, Sreih, Antoine, Alibaz-Oner, Fatma, Gul, Ahmet, Kamali, Sevil, Hatemi, Gulen, Kermani, Tanaz, Mackie, Sarah L., Mahr, Alfred, Meara, Alexa, Milman, Nataliya, Nugent, Heidi, Robson, Joanna, Tomasson, Gunnar, Merkel, Peter A.
Materialtyp: Artigo
Språk:Inglês
Publicerad: 2015
Ämnen:
Article
Länkar:https://ncbi.nlm.nih.gov/pmc/articles/PMC4668221/
https://ncbi.nlm.nih.gov/pubmed/26077399
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3899/jrheum.141144
Taggar: Lägg till en tagg
Inga taggar, Lägg till första taggen!

Liknande verk